Tg Therapeutics (TGTX) Return on Capital Employed Growth (3y) (2015 - 2026)
Tg Therapeutics (TGTX) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - | - |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 4,853.00 |
| 10 | Tg Therapeutics | 8.17 Bn | 8.09 Bn | 171.41 Mn | 15,582.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,582.00 |
| Dec 31, 2025 | 15,698.00 |
| Sep 30, 2025 | 13,238.00 |
| Jun 30, 2025 | 13,822.00 |
| Mar 31, 2025 | 12,557.00 |
| Dec 31, 2024 | 11,324.00 |
| Sep 30, 2024 | 9,447.00 |
| Jun 30, 2024 | 11,590.00 |
| Mar 31, 2024 | 8,239.00 |
| Dec 31, 2023 | 8,300.00 |
| Sep 30, 2023 | 8,846.00 |
| Jun 30, 2023 | 1,065.00 |
| Mar 31, 2023 | 12,401.00 |
| Dec 31, 2022 | 24,353.00 |
| Sep 30, 2022 | 81,967.00 |
| Jun 30, 2022 | 16,163.00 |
| Mar 31, 2022 | 8,638.00 |
| Dec 31, 2021 | 3,781.00 |
| Sep 30, 2021 | -2,291.00 |
| Jun 30, 2021 | -1,562.00 |